
Revolutionising CRISPR-Cas
Researchers have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously.
Researchers have refined the famous CRISPR-Cas method. Now, for the very first time, it is possible to modify dozens, if not hundreds, of genes in a cell simultaneously.
Engineers have combined CRISPR with electronic transistors made from graphene to create a new hand-held device that can detect specific genetic mutations in a matter of minutes.
Scientists find new and smaller gene editor: the new gene-editing protein, CasX, may give CRISPR-Cas9 a run for its money.
Researchers successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, affecting more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.
Researchers have repurposed the gene-editing tool CRISPR to study which genes are targeted by particular antibiotics, providing clues on how to improve existing antibiotics or develop new ones.
Researchers have given CRISPR-Cas9 an “on” switch, allowing users to keep the #Cas9 gene editor turned off in all cells except its designated target.
Scientists plan to edit their genomes to correct rare genetic mutations and slow or halt progression of their diseases.
Research project is aimed at improving therapeutic options for both rare and common diseases, including supporting methods to improve editing the human genome.